Cargando…
Response to Pneumococcal Polysaccharide Vaccination in Newly Diagnosed HIV-Positive Individuals
BACKGROUND: Newly diagnosed HIV-positive individuals are 35 to 100-fold more susceptible to Streptococcus pneumoniae infection compared to non-infected individuals. Therefore, the 23-valent pneumococcal polysaccharide vaccine (PPV23) has previously been recommended, though efficacy and effectiveness...
Autores principales: | Leggat, David J, Iyer, Anita S, Ohtola, Jennifer A, Kommoori, Sneha, Duggan, Joan M, Georgescu, Claudiu A, Khuder, Sadik A, Khaskhely, Noor M, Westerink, MA Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405239/ https://www.ncbi.nlm.nih.gov/pubmed/25908995 http://dx.doi.org/10.4172/2155-6113.1000419 |
Ejemplares similares
-
Response to Pneumococcal Polysaccharide Vaccination in HIV-Positive Individuals on Long Term Highly Active Antiretroviral Therapy
por: Iyer, Anita S, et al.
Publicado: (2015) -
Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults
por: Iyer, Anita S., et al.
Publicado: (2016) -
Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity
por: Kolibab, Kris, et al.
Publicado: (2005) -
Pneumococcal pericarditis in a patient with newly diagnosed diabetes mellitus: a case report
por: Dijkstra, Suzan, et al.
Publicado: (2022) -
Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)